MetLife Investment Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

MetLife Investment Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,016	Closed	-$206K	–	2920
2022 Q1	$206K	Buy	14,016 +5,173	+58%	+$69.2K	﹤0.01%	2341
2021 Q4	$140K	Hold	8,843	–	–	﹤0.01%	2277
2021 Q3	$284K	Hold	8,843	–	–	﹤0.01%	1854
2021 Q2	$368K	Buy	8,843 +5,457	+161%	+$224K	﹤0.01%	1755
2021 Q1	$172K	Buy	+3,386	New	+$177K	﹤0.01%	2132

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

MetLife Investment Management's DMTK Position: Q2 2022 in Review

MetLife Investment Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 14,016 shares — an estimated $206K sold.

MetLife Investment Management first reported a position in DMTK in Q1 2021 and held it in 5 quarters. The position peaked at $368K in Q2 2021. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

MetLife Investment Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
MetLife Investment Management sold 14,016 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $206K.
MetLife Investment Management first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
MetLife Investment Management's DermTech, Inc. Common Stock position peaked at $368K in Q2 2021.
134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.